Common Questions:
1. What is Semaglutide and Tirzepatide?
2. How do these medications work?
3. Why are these medications used for weight loss?
4. What are the benefits of these medications?
5. How are they taken?
6. Which Medication is Right for Me: Tirzepatide or Semaglutide?
___________________________________________________________
Possible Side Effects of Semaglutide and Tirzepatide:
While Semaglutide and Tirzepatide are highly effective for weight loss, like all medications, they may cause side effects. It's important to understand what to expect and how to manage any potential discomfort.
Common Side Effects:
General Recommendations for All Patients: Strategies for Preventing and Managing Side Effects
Before starting peptide-based medications, it's important to inform Dr. Tolman of any existing medical conditions or allergies, as these treatments may not be suitable for everyone. During your consultation, we will carefully review your health history and lifestyle to determine which medication is most appropriate for your weight loss journey. Our goal is to provide a personalized treatment plan tailored to your specific needs.
Start investing in yourself
Tirzepatide is a groundbreaking therapy that functions as a dual GIP and GLP-1 receptor agonist. It mimics the actions of both incretin hormones, enhancing glucose-dependent insulin secretion by the pancreatic beta cells, thereby regulating blood glucose levels. Furthermore, Tirzepatide slows down gastric emptying and suppresses appetite, contributing to weight loss, a significant benefit for patients with type 2 diabetes. Thus, this promising therapy addresses both hyperglycemia and obesity, typical in many diabetics.
Both tirzepatide (Mounjaro®) and semaglutide (Ozempic®, Wegovy®) exhibit promising results in improving metabolic health, reducing hemoglobin A1C (hbA1C) levels, and aiding in weight loss. Furthermore, data suggests that these drugs may decrease the risk of cardiovascular events such as heart attacks or strokes and enhance cardiovascular outcomes.
Semaglutide Therapy is FDA-approved weight loss medication therapies. The medications are administered once weekly via subcutaneous injection and produce an average weight loss of 50 lb over 6 months of treatment. It belongs to a class of drugs called GLP-1 receptor agonists, which work by increasing insulin release and reducing glucose production in the liver
The specific dosages vary, and it is important for individuals to adhere strictly to Dr. Tolman's prescribed instructions for optimal and safe results.
C. JONES
J. MILER
L. DRIPER
All Rights Reserved | NSI
Disclaimer: All information presented in this website is intended for informational purposes only and not for the purpose of rendering medical advice. The information contained herein is not intended to diagnose, treat, cure or prevent any disease.